Finance

Tyson Foods beats analyst expectations amid multiprotein model strength

https://www.investing.com/news/earnings/tyson-foods-beats-analyst-expectations-amid-multiprotein-model-strength-5029613 Investing.com

Current price of oil as of Nov. 16, 2026

:m-0 :text-accent pb-1 font-graphik-compact font-semibold hover:text-primary-hover **:hover:text-primary-hover group-focus-within:text-accent md:group-focus-within:stroke-accent group-open:stroke-accent **:no-underline!">How is the current price of oil per barrel actually determined? The current price...

Bicara at jefferies conference: lead cancer drug nears key test

https://www.investing.com/news/transcripts/bicara-at-jefferies-conference-lead-cancer-drug-nears-key-test-93CH-5029459 Investing.com

X4 Pharmaceuticals at Jefferies: oral neutropenia bet nears key test

https://www.investing.com/news/transcripts/x4-pharmaceuticals-at-jefferies-oral-neutropenia-bet-nears-key-test-93CH-5029460 Investing.com

Monte Rosa Therapeutics at UBS biopharma conference: pipeline takes center stage

https://www.investing.com/news/transcripts/monte-rosa-therapeutics-at-ubs-biopharma-conference-pipeline-takes-center-stage-93CH-5029461 Investing.com

Larimar Therapeutics director Frank Thomas to buy $21,800 stock

https://www.investing.com/news/insider-trading-news/larimar-therapeutics-director-frank-thomas-to-buy-21800-stock-93CH-5029349 Investing.com

Globalstar VP & CFO Rebecca Clary sells $2M in GSAT stock

https://www.investing.com/news/insider-trading-news/globalstar-vp--cfo-rebecca-clary-sells-2m-in-gsat-stock-93CH-5029350 Investing.com

Larimar Therapeutics CEO Carole Ben-Maimon buys $49,953 in stock.

https://www.investing.com/news/insider-trading-news/larimar-therapeutics-ceo-carole-benmaimon-buys-49953-in-stock-93CH-5029351 Investing.com

Latest articles

spot_imgspot_img